Emerging concepts and spectrum of renal injury following Intravesical BCG for non-muscle invasive bladder cancer

Abstract Background Intravesical Bacilli Calmette-Guerin (IVBCG) therapy for non-muscle invasive bladder cancer (NMIBC) has long been in use successfully. Albeit rarely, we still face with its safety concerns more than 25 years on since its approval by US Food and Drug Agency in 1990. Local and syst...

Full description

Bibliographic Details
Main Authors: Azharuddin Mohammed, Zubair Arastu
Format: Article
Language:English
Published: BMC 2017-12-01
Series:BMC Urology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12894-017-0304-5